Stocks

Spruce Biosciences SPRB

Health care sectorNasdaq

What to see in Spruce Biosciences now

Is Wall Street adding or cutting?+31

63 13F filers hold it · +31 against the quarter before · shares held +168.4%

Holdings of 06/30
Who bought more than 5%?4.8%

Orbimed Advisors holds 4.8%

Filed 08/14
What comes next?10/16 (Fri)

10/16 estimated earnings

Due 10/16

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
South San Francisco, California
Fiscal year end
12/31
Next earnings
10/16, estimated
  • 10/16 estimated earningsDue 10/16
Exchange
Nasdaq
Headquarters
California
SIC code
Pharmaceutical Preparations
Fiscal year end
12/31
CEO pay (proxy)
$2.9M · year ended 25/12/31
CEO pay actually paid
$4.2M · year ended 25/12/31
Next earnings (estimated)
10/16
Last earnings filing
08/12
Korean holdings rank
Outside the top 50

The next earnings day is estimated from the spacing of the last four quarters' 8-K filings.

Korea Securities Depository · released 09/22

Corporate actions

26-week trading